Related Experiment Video
Updated: Sep 29, 2026

Establishment of a Clinic-based Biorepository
Published on: May 29, 2017
Fourteen cases of sarcomatous degeneration in Paget's disease
F Jattiot1, P Goupille, I Azais
1Department of Rheumatology, Tours University, France.
Objective:
To describe characteristics of cases of sarcomatous degeneration in Paget's disease (SDP) recorded over 10 years in 2 French university hospitals, with particular emphasis on the pattern of this entity on magnetic resonance imaging (MRI).
Methods:
Fourteen cases are described. Epidemiological, clinical, radiological, histological, and MRI features (in 3 cases) are compared to others in the literature.
Results:
Nine men and 5 women (mean age 75.2+/-7.7 yrs) were studied. Paget's disease was monostotic in 5 cases and polyostotic in 9. Neurological complications were present in 10 cases. The mean interval between the first clinical signs and diagnosis was 4.4+/-4.7 months. The locations were: limbs 2, skull 2, pelvis 7, sacrum 3. The radiological pattern was lytic in 9 cases, sclerotic in 3, and mixed in 2. MRI revealed a similar pattern in all 3 cases studied (heterogeneous low signal intensity of the tumor on T1 weighted images increased after intravenous gadolinium administration and high signal intensity on T2 weighted images), whereas the radiological pattern was lytic in 2 cases and sclerotic in one case. The diagnosis was proved by histological investigation in 11/14 patients (osteogenic sarcoma of different appearance in 7 patients, fibroblastic sarcoma in one, fibrous histiocytoma-like sarcoma in one, and undifferentiated sarcoma in 2). Four patients had pulmonary metastases and 4 patients are still alive with followup ranging from 5 months to 5 years.
Conclusion:
Paget sarcomas remain the most threatening sarcomas of bone, their prognosis being far more negative than primary sarcomas. Improvement in therapy strategies including surgery, radiation therapy, and chemotherapy might together provide better prognosis for SDP.
Insights
Sarcomatous degeneration in Paget's disease (SDP) is a rare but aggressive bone cancer. Early diagnosis and multimodal therapy are crucial for improving the poor prognosis of these challenging bone sarcomas.
Area of Science:
- Oncology
- Orthopedic Surgery
- Radiology
Background:
- Paget's disease of bone is a chronic condition.
- Sarcomatous degeneration in Paget's disease (SDP) is a rare but serious complication.
- SDP is associated with a poor prognosis compared to primary bone sarcomas.
Purpose of the Study:
- To characterize cases of sarcomatous degeneration in Paget's disease (SDP).
- To emphasize the magnetic resonance imaging (MRI) patterns of SDP.
- To compare findings with existing literature.
Main Methods:
- Retrospective analysis of 14 cases over 10 years from two French university hospitals.
- Review of epidemiological, clinical, radiological, histological, and MRI data.
- Comparison of collected data with published literature.
Main Results:
- The study included 14 patients (9 men, 5 women, mean age 75.2 years).
- Paget's disease was monostotic in 5 and polyostotic in 9 cases, with neurological complications in 10.
- Common locations included the pelvis (7 cases) and sacrum (3 cases), with a predominantly lytic radiological pattern (9 cases). MRI showed a heterogeneous pattern (low T1, high T2 signal intensity). Histological investigation confirmed various types of bone sarcoma in 11/14 patients. Four patients developed pulmonary metastases.
Conclusions:
- Sarcomas arising in Paget's disease (SDP) represent a highly aggressive bone malignancy.
- The prognosis for SDP is significantly worse than for primary bone sarcomas.
- Multimodal treatment strategies, including surgery, radiation, and chemotherapy, may improve outcomes for patients with SDP.
Related Concept Videos
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Osteoclasts in Bone Remodeling
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...

